Cancer Research Journal
Overview
Publication venue for
- An exosomal miRNA-based liquid biopsy signature for the noninvasive early detection of pancreatic ductal adenocarcinoma. 82. 2022
- Circulating miR-125a-3p and miR-451a may be liquid biopsy biomarkers for the diagnosis of breast cancer. 82. 2022
- Gene expression and functional characterization of obesity-induced MDSC to uncover the link between obesity and cancer risk. 82. 2022
- Inverse correlation of circulating CD8+T cells with tumor burden from immune checkpoint treatment in humanized orthotopic model of renal cell carcinoma. 82. 2022
- Nanodrug delivery system for non-genotoxic p53 activator INZ-C. 82. 2022
- Nanodrug delivery system for non-genotoxic p53 activator INZ-C.. 82. 2022
- Role of micro-RNA 199a-3p in lymph node stromal extracellular vesicles on tumorigenesis in colorectal cancer. 82. 2022
- Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS.. 81. 2021
- A Phase I clinical trial: Use of 4-demethyl-4-cholesteryl-oxycarbonyl-penclomedine (DM-CHOC-PEN) plus radiation as treatments for cancers involving the CNS. 79. 2019
- A Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) S1609: The neuroendocrine cohort. 79. 2019
- Efficacy and safety of CB-839, a small molecule inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer (TNBC): Initial findings from a multicenter, open-label phase 2 study. 79. 2019
- Phase Ib clinical study of CBP501, cisplatin and nivolumab administered every 3 weeks in patients with advanced refractory tumors. Dose escalation cohort. 79. 2019
- Early phase I clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) plus radiation in cancers involving the CNS. 78. 2018
- Results from the early cancer clinical trials for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN). 75. 2015
- A phase I cancer clinical trial for 4-demethyl-4cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) IND 68.876. 74. 2014
- A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic or recurrent breast cancer patients with triple negative disease. 74. 2014
- The critical roles of tumor-initiating cell and lymph node stromal microenvironment in human colorectal cancer extranodal metastasis. 73. 2013
- Comparative pharmacokinetics for 4-demethy1-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) in humans. 72. 2012
Identity
International Standard Serial Number (ISSN)
- 0008-5472